About Hugo Braun
Form D filings for BlueWillow Biologics from 2016 to 2024 list Hugo Braun as director.
Hugo Braun first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Hugo Braun in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Hugo Braun works with at each company, as listed on that company's latest Form D.
BlueWillow Biologics, Inc. · Form D, Feb 12, 2024
PW
Phil Wilmington
Director
DS
David Stout
Director
RO
Roger D'Orazio
Director
GA
George Arida
Executive officer
CC
Chad Costley
President & Chief Executive Officer, director